Drug Fix: US FDA Undoes Podium Policy, Lessons From CDC, ASPR Confirmation Hearings

Pink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the impact of the US Food and Drug Administration clarifying that journal articles written by former commissioner Martin Makary and others were not official guidance (:58). They also discuss the questions an FDA commissioner nominee could field from Senators based on the recent confirmation hearing for President Trump’s US Centers for Disease Control and Prevention and Health and Human Services Assistant Secretary for Preparedness and Response nominees (15:12).

More On These Topics From The Pink Sheet

US FDA Says Two Makary, Prasad Journal Articles And NPV FAQ Were Not Policy Or Guidance: insights.citeline.com/pink-sheet/legislation/u…

US CDC, ASPR Nominees’ Confirmations In Question After Contentious Senate Hearing: insights.citeline.com/pink-sheet/agency-leader…